Respiratory Medicine
Volume 103, Issue 6 , Pages 902-906 , June 2009

Inhibition of cough-reflex sensitivity by benzonatate and guaifenesin in acute viral cough

  • Peter V. Dicpinigaitis

      Affiliations

    • Albert Einstein College of Medicine and Montefiore Medical Center, 1825 Eastchester Road, Bronx, NY, 10461, USA
    • Corresponding Author InformationCorrespondence to: Peter V. Dicpinigaitis, Einstein Division/Montefiore Medical Center, 1825 Eastchester Road, Bronx, NY 10461, USA. Tel.: +1 718 904 2676; fax: +1 718 904 2880.
    • ,
  • Yvonne E. Gayle

      Affiliations

    • Albert Einstein College of Medicine and Montefiore Medical Center, 1825 Eastchester Road, Bronx, NY, 10461, USA
    • ,
  • Gail Solomon

      Affiliations

    • Reckitt Benckiser, Inc., 399 Interpace Parkway, Parsippany, NJ, 07054, USA
    • ,
  • Richard D. Gilbert

      Affiliations

    • TKL Research, Inc., 365 West Passaic Street, Rochelle Park, NJ, 07662, USA

Received 8 September 2008 ,Accepted 9 December 2008.

References 

  1. Burt CW, Schappert SM. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1999–2000. Vital Health Stat. 2004;13(157):1–70
  2. Schroeder K, Fahey T. Systematic review of randomised controlled trials of over-the-counter medicines for acute cough in adults. Br Med J. 2002;324:329–331
  3. Bolser DC. Cough suppressant and pharmacologic protussive therapy: ACCP evidence-based clinical practice guidelines. Chest. 2006;129:238S–249S
  4. Eccles R, Morris S, Jawad M. Lack of effect of codeine in the treatment of cough associated with acute upper respiratory tract infection. J Clin Pharm Ther. 1992;17:175–180
  5. Freestone C, Eccles R. Assessment of the antitussive efficacy of codeine in cough associated with common cold. J Pharm Pharmacol. 1997;49:1045–1049
  6. Chung KF. Currently available cough suppressants for chronic cough. Lung. 2008;186(Suppl. 1):S82–S87
  7. Ayres PJW. Experimental and clinical methodologies in efficacy of expectorants using the example of guaifenesin. In:  Loew D,  Rietbrock N editor. Phytopharmaka III. Darmstadt, Germany: Steinkopff Verlag; 1997;p. 151–160
  8. United States Dept. of Health and Human Services . Expectorant drug products for over-the-counter human use: final monograph. Washington, DC: Federal Register 54; 1989;p. 8494–509
  9. Dicpinigaitis PV, Gayle YE. Effect of guaifenesin on cough reflex sensitivity. Chest. 2003;124:2178–2181
  10. Banner AS. Pharmacologic treatment of cough. In:  Leff AR editors. Pulmonary and critical care pharmacology and therapeutics. New York: McGraw-Hill; 2002;p. 673–679
  11. Ziment I. Agents that affect mucus and cough. In:  Witek TJ,  Schacter EN editor. Pharmacology and therapeutics in respiratory care. Philadelphia: WB Saunders; 1994;p. 239–257
  12. Dicpinigaitis PV. Short and long-term reproducibility of capsaicin cough challenge testing. Pulm Pharmacol Ther. 2003;16:61–65
  13. Dicpinigaitis PV, Alva RV. Safety of capsaicin cough challenge testing. Chest. 2005;128:196–202
  14. Morice AH, Fontana GA, Belvisi MG, et al. European Respiratory Society guidelines on the assessment of cough. Eur Respir J. 2007;29:1256–1276
  15. Empey DW, Laitinen LA, Jacobs L, Gold WM, Nadel JA. Mechanism of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis. 1976;113:131–139
  16. O'Connell F, Thomas VE, Studham JM, Pride NB, Fuller RW. Capsaicin cough sensitivity increases during upper respiratory tract infection. Respir Med. 1996;90:279–286
  17. Dicpinigaitis PV, Spinner L, Santhyadka G, Negassa A. Effect of tiotropium on cough reflex sensitivity in acute viral cough. Lung. 2008;186:369–374

PII: S0954-6111(08)00453-8

doi: 10.1016/j.rmed.2008.12.008

Respiratory Medicine
Volume 103, Issue 6 , Pages 902-906 , June 2009

Article Tools